# LIDDIA：语言驱动的智能药物发现代理

发布时间：2025年02月19日

`Agent` `人工智能`

> LIDDIA: Language-based Intelligent Drug Discovery Agent

# 摘要

> 药物发现是一个漫长、昂贵且复杂的过程，严重依赖药物化学家，他们可能需要花费数年时间在潜在疗法的广阔空间中搜寻。化学领域的人工智能最近取得了进展，试图加速药物发现的各个任务；然而，仍然迫切需要一种能够导航整个药物发现过程的智能代理。为此，我们引入了LIDDiA，一个能够在计算机模拟中自主导航药物发现过程的智能体。通过利用大型语言模型的推理能力，LIDDiA 成为一个低成本且高度适应性的自主药物发现工具。我们对LIDDiA进行了全面评估，证明了以下几点：（1）它能够在30个临床相关靶点中的70%以上生成符合关键药物标准的分子，（2）它在化学空间中能够智能地平衡探索与开发，（3）它能够识别EGFR（癌症治疗中的关键靶点）中具有前景的新型药物候选分子。

> Drug discovery is a long, expensive, and complex process, relying heavily on human medicinal chemists, who can spend years searching the vast space of potential therapies. Recent advances in artificial intelligence for chemistry have sought to expedite individual drug discovery tasks; however, there remains a critical need for an intelligent agent that can navigate the drug discovery process. Towards this end, we introduce LIDDiA, an autonomous agent capable of intelligently navigating the drug discovery process in silico. By leveraging the reasoning capabilities of large language models, LIDDiA serves as a low-cost and highly-adaptable tool for autonomous drug discovery. We comprehensively examine LIDDiA, demonstrating that (1) it can generate molecules meeting key pharmaceutical criteria on over 70% of 30 clinically relevant targets, (2) it intelligently balances exploration and exploitation in the chemical space, and (3) it can identify promising novel drug candidates on EGFR, a critical target for cancers.

[Arxiv](https://arxiv.org/abs/2502.13959)